Abstract
Abstract
Background
Older patients on dialysis may not have optimal outcomes, particularly with regards to quality of life. Existing research is focused mainly on survival, with limited information about other outcomes. Such information can help in shared decision-making around dialysis initiation; it can also be used to improve outcomes in patients established on dialysis. We used qualitative research methods to explore patient perspectives regarding their experience and outcomes with dialysis.
Methods
Semi-structured interviews with participants aged ≥70, receiving dialysis at a regional Australian hospital, were recorded and transcribed. From participants’ responses, we identified descriptive themes using a phenomenological approach, with verification by two researchers. Factors affecting outcomes were derived reflexively from these themes.
Results
Seventeen interviews were analysed prior to saturation of themes. Participants (12 on haemodialysis, 5 on peritoneal dialysis) had spent an average of 4.3 years on dialysis. There were 11 males and 6 females, with mean age 76.2 years (range 70 to 83). Experiences of dialysis were described across four domains - the self, the body, effects on daily life and the influences of others; yielding themes of (i) responses to loss (of time, autonomy, previous life), (ii) responses to uncertainty (variable symptoms; unpredictable future; dependence on others), (iii) acceptance / adaptation (to life on dialysis; to ageing) and (iv) the role of relationships / support (family, friends and clinicians).
Conclusions
Older patients experience the effects of dialysis across multiple domains in their lives. They endure feelings of loss and persistent uncertainty, but may also adapt successfully to their new circumstances, aided by the support they receive from family, health professionals and institutions. From these insights, we have suggested practical measures to improve outcomes in older patients.
Funder
Clifford Craig Foundation
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–82.
2. ANZDATA. Registry. 41st Report. Chapter 2: Prevalence of Renal Replacement Therapy for End Stage Kidney Disease. Adelaide, Australia: Australia and New Zealand: Dialysis and Transplant Registry; 2018. [cited 2019 Feb 28]. Available from: http://www.anzdata.org.au
3. Saran R, Robinson B, Abbott KC, Agodoa LYC, Bhave N, Bragg-Gresham J, et al. US renal data system 2017 annual data report: epidemiology of kidney disease in the united states. Am J Kidney Dis. 2018;71(3S1):A7.
4. MacNeill SJ, Ford D, Evans K, Medcalf JF. Chapter 2 UK renal replacement therapy adult prevalence in 2016: national and Centre-specific analyses. Nephron. 2018;139(Suppl 1):47–74.
5. Masakane I, Nakai S, Ogata S, Kimata N, Hanafusa N, Hamano T, et al. Annual dialysis data report 2014, JSDT renal data registry (JRDR). Ren Replace Ther. 2017;3(1):18.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献